Resiniferatoxin

CAS No. 57444-62-9

Resiniferatoxin( RTX | [3H]resiniferatoxin )

Catalog No. M28009 CAS No. 57444-62-9

Resiniferatoxin inhibits the production of Th1 cytokines, contributing to the defense against T. spiralis infection, and can be used in studies about the modulator of the immune response.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Resiniferatoxin
  • Note
    Research use only, not for human use.
  • Brief Description
    Resiniferatoxin inhibits the production of Th1 cytokines, contributing to the defense against T. spiralis infection, and can be used in studies about the modulator of the immune response.
  • Description
    Resiniferatoxin inhibits the production of Th1 cytokines, contributing to the defense against T. spiralis infection, and can be used in studies about the modulator of the immune response.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RTX | [3H]resiniferatoxin
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    HOXA9
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    57444-62-9
  • Formula Weight
    628.71
  • Molecular Formula
    C37H40O9
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (79.53 mM)
  • SMILES
    C[C@H]1[C@]23[C@]([C@@]4([C@](C(C)=C)(C1)O[C@](CC5=CC=CC=C5)(O2)O4)[H])(C=C(COC(CC6=CC(OC)=C(O)C=C6)=O)C[C@@]7(O)[C@]3(C=C(C)C7=O)[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sonoda Y, Itoh M, Tohda S. Effects of HOXA9 Inhibitor DB818 on the Growth of Acute Myeloid Leukaemia Cells. Anticancer Res. 2021 Apr;41(4):1841-1847.
molnova catalog
related products
  • 5-O-Caffeoylshikimic...

    5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB.

  • Nothofagin

    Nothofagin has antioxidant, and antithrombotic activities, it possesses anti-inflammatory activity by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.

  • Suplatast tosilate

    A Th2 cytokine inhibitor that attenuates IL-2, IL-5 and IL-13 production and has no effect on IFN-γ production.